Interestingly, GLP-1Ra given to OVA-sensitized mice also depressed the activity of oligomerization domain-like receptor protein (NLRP)3, which induces airway inflammation and AHR in obesity by upregulating levels of IL-17 secretion by ILC3 via secretion of IL-1 [109,110,111]
Quinine was once widely prescribed for nocturnal leg cramps but the FDA issued a safety alert in 2010 warning against off-label quinine use due to risk of thrombocytopenia and cardiac arrhythmias 18
Gala GLP-1 is designed for adults 18 years of age or older with high BMI, obesity, or weight-related health concerns
Your provider may recommend continuing berberine during the initial tirzepatide ramp-up phase while monitoring blood glucose closely, or they may suggest temporarily discontinuing berberine until your tirzepatide dose reaches therapeutic levels
About 75% had gastrointestinal side effects, but few discontinued treatment